
pmid: 18328481
To report a case of successful use of a transdermal contraceptive in a patient with hereditary angioedema.Case report.University medical center.A patient who had used oral contraceptives contracted SC and submucosal tumefaction every 1 or 2 months. She was diagnosed with type I hereditary angioedema. It was determined that she was complement C4 deficient and C1-inhibitor quantitative deficient but functional C1-inhibitor normal. After she was diagnosed, the use of oral contraceptives was contraindicated.Oral contraceptives were suspended, and a hormonal transdermal contraceptive was started.The absence of symptoms after 26 months using a transdermal contraceptive.After 26 months of using this treatment, the patient has not experienced any symptoms of the hereditary angioedema.The use of hormonal contraceptives transdermally can be an alternative in patients with hereditary angioedema.
Drug Combinations, Norgestrel, Angioedemas, Hereditary, Humans, Female, Administration, Cutaneous, Ethinyl Estradiol, Contraceptives, Oral, Hormonal
Drug Combinations, Norgestrel, Angioedemas, Hereditary, Humans, Female, Administration, Cutaneous, Ethinyl Estradiol, Contraceptives, Oral, Hormonal
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
